Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Horizon Therapeutics PUB L

CUSIP: G46188951 | 14 institutional holders

Quarters

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile